Case Study: a Swiss biologics company accelerates China BLA sample testing with FREYR

Swiss Biologics Company completes China BLA sample testing on time with FREYR

A Swiss biologics company needed to complete critical sample testing and regulatory operations for a Biologics License Application (BLA) in China. They faced challenges with tight timelines, evolving NMPA requirements, and complex coordination with multiple stakeholders. To overcome this, they partnered with FREYR for comprehensive regulatory affairs support and BLA sample testing coordination.

FREYR provided a solution that included sample testing coordination, regulatory documentation support, and proactive NMPA communication management. This enabled the client to successfully complete all required activities within the project timelines, minimizing potential delays. FREYR's support accelerated the BLA review process and strengthened the client's overall market access strategy for China.